Evidence Hub

Efficacy and safety of Wanfeile in the treatment of erectile dysfunction: Report of 100 cases and review of the literature

Chen WJ, Cao J, Zhu XW, Sun Z, Fu Q, Liu XL

Zhonghua nan ke xue = National journal of andrology, 2017

100 participants

Abstract

OBJECTIVE: To investigate the clinical effect and safety of Wanfeile in the treatment of erectile dysfunction (ED).

METHODS: Totally 100 ED patients received oral Wanfeile at 100 mg, once every 3 days, for a course of 3 months. We compared the IIEF-5 scores of the patients before and after medication and among the patients with different degrees of ED. We evaluated the total clinical effectiveness of Wanfeile and analyzed adverse reactions.

RESULTS: The total effectiveness rate of Wanfeile was 95.6%. All the patients showed significant improvement in the IIEF-5 scores after treatment as compared with the baseline (P <0.05). Adverse reactions were observed in 5 cases (5.50%), all mild and transient.

CONCLUSIONS: Wanfeile is safe and efficacious for the treatment of ED.

目的: 探讨万菲乐治疗男性勃起功能障碍的临床疗效观察及安全性。方法: 100例ED患者口服100 mg 万菲乐3日1次,3个月为1个疗程,比较治疗前后国际勃起功能指数调查表5个简化问题(IIEF-5)的评分,评估临床总有效率以及观察不良反应。结果: 万菲乐治疗ED患者的临床总有效率达95.6%,不同程度组的ED患者IIEF评分均较治疗前有统计学差异(P<0.05),发生药物不良反应共5例(5.50%),均是一过性的,程度轻微。结论: 万菲乐治疗男性勃起功能障碍是安全有效的。.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free